Page last updated: 2024-09-04

atrasentan and Cardiovascular Diseases

atrasentan has been researched along with Cardiovascular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Aubert, JD; Juillerat-Jeanneret, L1
Abdelhady, SA; Darwish, IE; El-Deeb, NM; El-Mas, MM; Gowayed, MA; Habib, YH1
Parving, HH; Rossing, P1
Brunner, F; Kirchengast, M; Pang, X; Stessel, H; Wölkart, G1

Reviews

1 review(s) available for atrasentan and Cardiovascular Diseases

ArticleYear
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis.
    Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18

    Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrosis; Humans; Hypertension, Pulmonary; Neoplasms; Receptors, Endothelin

2016

Other Studies

3 other study(ies) available for atrasentan and Cardiovascular Diseases

ArticleYear
Modulation by antenatal therapies of cardiovascular and renal programming in male and female offspring of preeclamptic rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:11

    Topics: Animals; Atrasentan; Cardiovascular Diseases; Disease Models, Animal; Endothelin A Receptor Antagonists; Female; Kidney Diseases; Male; Methyldopa; Naphthalenes; NG-Nitroarginine Methyl Ester; Pre-Eclampsia; Pregnancy; Prenatal Care; Propionates; Rats; Receptors, Thromboxane A2, Prostaglandin H2; Sex Factors; Sympatholytics

2021
Diabetic nephropathy in 2014: improved cardiorenal prognosis in diabetic nephropathy.
    Nature reviews. Nephrology, 2015, Volume: 11, Issue:2

    Topics: Atrasentan; Cardiovascular Diseases; Diabetic Nephropathies; Endothelin Receptor Antagonists; Humans; Prognosis; Pyrrolidines

2015
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
    British journal of pharmacology, 2007, Volume: 151, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Fibrosis; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Oxidative Stress; Pyrrolidines; Ramipril; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left; Ventricular Pressure

2007